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In the early stages of lung development, the endoderm undergoes extensive and stereotypic branching morphogenesis. During this process, a
simple epithelial bud develops into a complex tree-like system of tubes specialized for the transport and exchange of gas with blood. The
endodermal cells in the distal tips of the developing lung express a special set of genes, have a higher proliferation rate than proximal part, undergo
shape change and initiate branching morphogenesis. In this study, we found that of the four p38 genes, only p38α mRNA is localized specifically
to the distal endoderm suggesting a role in the regulation of budding morphogenesis. Chemical inhibitors specific for the p38α and p38β isoforms
suppress budding of embryonic mouse lung explants and isolated endoderm in vitro. Specific knockdown of p38α in cultured lung endoderm
using shRNA also inhibited budding morphogenesis, consistent with the chemical inhibition of the p38 signaling pathway. Disruption of p38α did
not affect proliferation or expression of the distal cell markers, Sox9 and Erm. However, the amount of E-cadherin protein increased significantly
and ectopic expression of E-cadherin also impaired budding of endoderm in vitro. These results suggest that p38α modulates epithelial cell–cell
interactions and possibly cell rearrangement during branching morphogenesis. This study provides the first evidence that p38α is involved in the
morphogenesis of an epithelial organ.
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Mouse lung branching morphogenesis starts from embryonic
day 9.5 (E9.5) when two primordial buds appear at the ventral
lateral side of the foregut. The inner layer of the primordial bud
is composed of endodermal epithelial cells and is surrounded by
mesenchymal cells derived from mesoderm. Between E9.5 and
E16.5 (the pseudoglandular stage), the primordial bud under-
goes repetitive rounds of budding and branching to give rise to a
tree-like structure. This process is regulated by reciprocal
interactions between the epithelial cells and the surrounding
mesenchyme and is mediated by extracellular signaling
molecules, cell membrane receptors and intracellular signaling⁎ Corresponding author.
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epithelial cells at the distal tips of the developing lung undergo
several changes, including increased proliferation rate, coordi-
nated cell shape changes and the generation of the precursors of
different cell types along the proximal–distal axis. Thus, the
epithelial cells in the distal tip and proximal stalk have distinct
phenotypes, including different proliferation rates and cell
shape (Cardoso, 2001; Hogan and Yingling, 1998; Warburton et
al., 2000). In addition, these two populations of cells express
different sets of genes. For example, Bmp4, Erm, Zdhhc6 and
Sox9 are expressed at the distal tip while Netrin-1 and -4 are
expressed in more proximal regions (Liu and Hogan, 2002; Liu
et al., 2003, 2004).
Members of several families of conserved signaling
molecules, including fibroblast growth factor (FGF), Sonic
hedgehog, bone morphogenetic protein/transforming growth
factor-β, Wnt, epidermal growth factor and platelet-derived
growth factor families, are expressed in lung during the
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studies using genetically modified mice have highlighted the
role of FGF signaling during lung development. For example,
FGF receptor isoform 2 IIIb (FGFR2IIIb) in the endoderm is
essential for normal branching morphogenesis during lung
development. Pulmonary agenesis is seen in FGFR2IIIb-null
mice in addition to other developmental defects (De
Moerlooze et al., 2000) and transgenic expression of a
dominant negative form of FGFR2IIIb in lung epithelium
inhibits branching morphogenesis (Peters et al., 1994).
Activating ligands of FGFR2IIIb include FGF7 and FGF10,
which are released from the mesenchyme (Bellusci et al.,
1997; Ornitz et al., 1996), bind receptors and initiate
downstream signals. Although activation of FGFR2IIIb is
required for normal branching morphogenesis and lung
development, the specific downstream signaling events
involved are largely uncharacterized. It is well established
that mitogen-activated protein kinases (MAPKs) are key
downstream components of FGF signaling pathways in
numerous cell types. The MAPK family is divided into
three subfamilies based on their activation motifs: extra-
cellular signal-regulated protein kinase (ERK) has a Thr-Glu-
Tyr motif; Jun NH2-terminal kinase (JNK) has a Thr-Pro-Tyr
motif; and p38 kinase has a Thr-Gly-Tyr motif. MAPKs have
been shown to regulate several critical cellular functions
including proliferation, differentiation, and migration (Pearson
et al., 2001). ERK1 and ERK2 are MAPKs typically
activated by FGFs in several cell types and previous studies
suggest that they are important for normal lung development
(Liu et al., 2004). In this study we provide evidence
supporting a functional role for p38 MAPK in lung branching
morphogenesis.
Initially, p38 kinase was characterized as an inflammatory or
stress-activated kinase in a wide variety of cell types.
Subsequently, p38 activation has been seen in response to
growth factors including FGFs, as well as cytokines, UV light,
heat and osmotic stress. Like all MAPKs, p38 is activated
through a cascade of kinases broadly defined as MAPK kinase
kinases (MKKKs) and MAPK kinases (MKKs). Included in
these groups of upstream activators are mixed-lineage kinase 3
(MLK3), dual leucine zipper-bearing kinase (DLK) and
mitogen-activated protein kinase kinase 3/6 (MKK3/6). The
downstream targets of p38 include MAPK-activated protein
kinases 2/3 (MAPKAP2), heat shock protein 25/27 (HSP25/27)
and several transcription factors such as activating transcription
factor-2 (ATF-2) and myocyte enhancer factor-2 (MEF2)
(Herlaar and Brown, 1999). Recently, p38 signaling has been
implicated in normal developmental processes, such as wing
development in Drosophila and muscle formation in Xenopus
(Adachi-Yamada et al., 1999; Keren et al., 2005; Nebreda and
Porras, 2000). Four p38 genes have been identified in mice:
p38α/MAPK14, p38β/MAPK11, p38δ/MAPK13 and p38γ/
MAPK12 (Kuida and Boucher, 2004). Although all four
isoforms are activated by stress and mitogenic stimuli, distinct
functional roles for each are suggested, especially during
mammalian development. Disruption of p38β or p38γ does not
cause a detectable developmental defect (Kuida and Boucher,2004) and a p38δ mutant mouse has not been reported. On the
other hand, p38α null mutant mice die at E12.5 apparently due
to a defect in placental angiogenesis (Tamura et al., 2000).
Recently, an embryo-specific deletion of p38α was generated
by crossing mice with floxed p38α allele to mice with aMORE-
cre allele. These p38α-null mice die shortly after birth with
distorted alveolar structures and massive infiltration of
hematopoietic cells in the lung. Whether a defect in branching
morphogenesis coexists is not clear since morphometric
analysis of the lungs prior to the massive hematopoietic cell
infiltration at E17.5 was not performed (Hui et al., 2007).
Postnatal deletion of p38α revealed an important regulatory role
for p38α in lung stem and progenitor cell proliferation and
differentiation (Ventura et al., 2007).
Additional evidence suggests that the p38α isoform has
several important roles during development. A chemical
inhibitor SB203580 that specifically inhibits p38α and β
impairs cavity formation in mouse blastocysts before implanta-
tion (Maekawa et al., 2005). Recently, a mouse mutation
disrupting p38-interacting protein (p38IP or droopy eye) was
shown to result in neural tube, eye and gastrulation defects.
p38IP appears to specifically interact with p38α, but not other
p38 isoforms, resulting in its activation. In the absence of
normal p38IP activation of p38 signaling, E-cadherin down-
regulation and mesoderm migration away from the primitive
streak are impaired during gastrulation (Zohn et al., 2006).
In this study, we found that the expression pattern of
p38α suggests a role in mouse lung branching morphogenesis.
Chemical inhibition of p38α/β reduced distal bud formation in
embryonic whole lung explants. Using a three-dimensional
culture system, we disrupted p38α in the embryonic lung
endoderm with either chemical inhibitors or short hairpin RNA
(shRNA). Both methods of targeting the p38α signaling
pathway blocked budding morphogenesis. In addition, disrup-
tion of p38α and inhibition of budding was associated with
increased levels of E-cadherin protein. Ectopic expression of
E-cadherin was sufficient to inhibit secondary budding of
isolated endoderm. We propose that p38α plays a role in
regulating E-cadherin levels related to epithelial branching
morphogenesis.
Materials and methods
In situ hybridization
Whole-mount in situ hybridization was performed by using digoxygenin-
labeled anti-sense RNA probes as described (Liu et al., 2003). The probes for
p38α, δ, γ were generated from IMAGE clones 5100700 (GenBank number
BI220793), 6397838 (GenBank number BQ926696), 6333323 (GenBank
number BQ899725), respectively. The probes for p38β were derived from RT-
PCR products using primer 5′-CCATGAAATTGAGCAGTG-3′ and 5-AGT-
TACTTGGTCAGCTCC-3′. For all probes, sense RNAwas used as control and
none of them show detectable signal.
Embryonic whole lung explant culture
Lungs were dissected from ICR mice at E11.5 (noon on the day of plug is
E0.5) and cultured in Costar Transwell plates (3-μm pores) containing BGJb
medium supplemented with 0.2 mg/ml ascorbic acid and penicillin/streptomycin
(P/S) in the lower chamber as described (Kling et al., 2002). Media were
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MicroPublisher 5.0 camera attached to a Leica MZ9.5 stereoscope. Images
were captured using QCapture Pro software and imported into Adobe Photoshop
to count the terminal buds. Heparin-acrylic beads (Sigma) were soaked in
FGF10 or BSA solutions (100 ng/μl) for 1 h at RT prior to use.
Lung endodermal culture
Lungs were dissected from ICR mice at E11.5. Distal endoderm was
separated from mesenchyme and cultured in growth factor reduced Matrigel as
described (Nogawa and Ito, 1995). The endoderm was cultured in a serum-free
medium consisting of Ham's F12:DMEM 1:1, 1% BSA and 2 mM glutamine.
The media were supplemented with recombinant FGF7 (30 ng/ml) or FGF10
(250 ng/ml) as indicated (R&D Systems). In some experiments, chemical
inhibitors SB203580, SB202190 or SP600125 (Calbiochem) were added at
10 μM, U0126 was added at 5 μM, at 24 h after culture initiation. In other
experiments, the endoderm was infected with lentivirus at the time of isolation
and initial culturing. The endoderm was cultured for a designated time, released
from Matrigel and processed for immunohistochemistry, Western blot analysis
or real-time RT-PCR analysis. Each culture condition was repeated at least three
times with about ten endoderm samples per experiment.
Cell culture
LA-4 cells (a generous gift from Marc B. Hershenson, University of
Michigan) were cultured in DMEM supplemented with 10% fetal bovine serum
(FBS) and P/S at 37 °C in 5% CO2 (Stoner et al., 1975). The cells were serum
starved for 24 h in DMEM containing 0.2% BSA and P/S before treatment with
FGF7 or FGF10.
Lentiviral constructs, production and transduction
The shRNA constructs were generated using the lentiviral transfer vector
pLVTHM (a generous gift from Dr. Didier Trono at Swiss Institute of
Technology Lausanne, Switzerland). This vector contains a self-inactivating
long terminal repeat (SIN LTR), a human H1 promoter for expression of the
shRNA and a GFP marker expressed from an EF1α promoter (Wiznerowicz and
Trono, 2003). The targeting sequences for shRNA constructs were as follows:
5′-GGTCACTGGAGGAATTCAA-3′ and 5′-GGCATCGTGTGGCAGTTAA-
3′ for mouse p38α; and 5′-GAATGTTATAGGCATCCGA-3′ for mouse ERK1.
PCR was used to add a carboxy-terminal FLAG epitope tag to full-length
mouse E-cadherin cDNA (a generous gift from Masatoshi Takeichi, RIKEN
Center for Developmental Biology, Japan). The FLAG-tagged E-cadherin was
cloned into the lentiviral transfer vector pWPI (a generous gift from Dr. Didier
Trono at Swiss Institute of Technology Lausanne, Switzerland) which contains
an SIN LTR, a human EF1α promoter for expression of the gene of interest and
GFP expressed from an internal ribosomal entry site (Pham et al., 2004).
Lentivirus was produced by co-transfecting HEK293T cells with a transfer
vector together with a second generation packaging vector, psPAX2 (a generous
gift from Didier Trono) and the VSV-G envelope protein vector, pHCMV-G (a
generous gift from Dr. Garry Nolan, Stanford) (Wolkowicz et al., 2004). The
medium containing virus was harvested 48 h post-transfection and the virus was
concentrated by centrifugation at 6000×g for 24 h at 4 °C (Nanmoku et al.,
2003). The titer of the viral supernatant was determined using serial dilutions to
infect NIH 3T3 cells. Successfully transduced cells were identified by the
expression of GFP detected by fluorescence microscopy. The percentage of
GFP-positive cells was determined by manual counting and normalized to the
total number of cell present in one field. A titer of 107 to 108 transducing units
per milliliter was typically obtained. Experiments were repeated using at least
three independently prepared batches of control and shRNA expressing virus
with matched viral titers.
Immunohistochemistry and immunoblotting
Whole-mount antibody staining of cultured lung endoderm was performed
as previously described (Liu et al., 2004). Anti-phospho-histone H3 (Ser10)
(Upstate Cell Signaling) was used at 1 μg/ml and anti-E-cadherin (BDTransduction Laboratories) was used at 0.25 μg/ml. Cy3-conjugated secondary
antibodies (Jackson Immunoresearch) were used at concentrations recom-
mended by manufacturer. In a certain experiment, the tissues were also labeled
with 0.13 μM Alexa Fluor 488 phalloidin or propidium iodide as previously
described (Liu et al., 2004). The fluorescence images were captured using a
Zeiss LSM 510 confocal microscopy (University of Chicago Cancer Research
Center Integrated Microscopy Facility). Immunoblotting of the cultured
endodermwas performed as previously described (Liu et al., 2004). Specifically,
protein extracts of 30 endoderm samples were loaded on each lane and the
following primary antibodies were used: anti-p38α (Chemicon) at 0.5 μg/ml;
anti-β-actin (Abcam) at 0.1 μg/ml; anti-phospho-histone H3 (Ser10) (Upstate
Cell Signaling) at 1 μg/ml; anti-E-cadherin (BD Transduction Laboratories) at
0.25 μg/ml; and anti-Sox9 (Abcam) at 0.5 μg/ml. Total and phospho-specific
p42/44 kinase antibodies (Cell Signaling) were used at a 1:1000 dilution.
Protein quantification by Western analysis was determined using densito-
metric scanning (SigmaScan Pro, Jandel Corp., San Rafael, CA) as previously
described (Abe et al., 2001) with normalization to β-actin protein levels.
RNA isolation, reverse transcription and real-time RT-PCR
Total RNA isolation and reverse transcription (RT) were performed using the
RNAqueous-4PCR kit (Ambion) according to the manufacturer's protocol.
DNAse I treated total RNA from about 30 cultured lung endoderm samples was
used per RT reaction with an oligo-dT primer and either MMLV-RT or water.
Real-time RT-PCR (qRT-PCR) reactions were performed on an Applied
Biosystems 7300 Real Time PCR System running Sequence Detection Software
v1.2.3. Real-time primer sets were designed using the Primer Express software
(Applied Biosystems): ERM, 5′-GCCGAGGCATGGAATTTAAG-3′ and 5′-
AGAGCGGCTCAGCTTGTCATA-3′; E-cadherin, 5′-AAAATCCATCT-
CAAGCTCGCG-3′ and 5′-ATTCCCGCCTTCATGCAGTT-3′; Rab7, 5′-
AAGGAGGCCATCAATGTGGAG-3′ and 5′-CCCGGTCATTCTTGTC-
CAGTT-3′; Snail, 5′-TTCCTGCTTGGCTCTCTTGGT-3′ and 5′-TATGGCTC-
GAAGCAGCTGTGT-3′; Slug, 5′-TGATGCCCAGTCTAGGAAATCG-3′ and
5′-GCCACAGATCTTGCAGACACAA-3′; and β-actin, 5′-CACTATTGG-
CAACGAGCGGT-3′ and 5′-TTCTGCATCCTGTCAGCAATG-3′. Primers
were used at a final concentration of 200 nM with SYBR Green Master Mix
(Applied Biosystems). Following a single denaturation step for 10 min at 95 °C,
40 cycles of two-step PCR was performed consisting of 15 s at 95 °C and 1 min
at 60 °C. Melting curve analysis and detection by gel electrophoresis with
ethidium bromide staining were performed to determine specificity of the PCR
products. Data were analyzed using the relative quantification RQ Study
Software (Applied Biosystems) using the comparative CT method. The amount
of target mRNAwas normalized to β-actin. Relative quantification to the control
sample calibrator was calculated using the formula 2-ΔΔCT. For each sample set,
the baseline and threshold (CT) were selected automatically with visual
verification.Results
Expression patterns of p38 isoforms in embryonic lung
To understand the role of p38 during branching morphogen-
esis, we compared the expression patterns of all four p38
isoforms in embryonic mouse lung at the pseudoglandular stage
by in situ hybridization. p38α is expressed as early as E10.5
(Fig. 1A). From E11.5 to E13.5, when the lung undergoes active
branching morphogenesis, p38α transcript is localized to the
endodermal epithelial cells and is enriched at the distal tips
(Figs. 1B and C). Epithelial cells in this region are most actively
engaged in budding and branching morphogenesis and have a
higher proliferation rate compared to the proximal region. They
also contain precursors of alveolar type I and II cells (Liu et al.,
2003; Perl et al., 2002; Weaver et al., 1999). Thus this pattern of
expression suggests that p38α is involved one or more of the
Fig. 1. Expression pattern of genes encoding four p38 isoforms during lung
branching morphogenesis. Whole-mount in situ hybridization was performed in
embryonic lungs during branching morphogenesis using anti-sense RNA probes
for p38α (A–C), p38β (D), p38δ (E) and p38γ (F). Three time points during the
pseudoglandular stage were analyzed: E10.5 (A); E11.5 (B, D, E, F); and E13.5
(C). (A) p38α is expressed at E10.5 shortly after the initiation of lung
development. At E11.5 (B) and E13.5 (C), when lung endoderm is actively
engaged in branching morphogenesis, p38α transcripts remain localized at the
distal tip of epithelium, the sites of active budding and branching. (D) p38β is
expressed in both the mesenchyme and epithelium with similar levels
throughout proximal and distal regions. (E) p38δ transcript is located in the
endoderm with similar levels of expression throughout proximal and distal
regions. (F) The expression level of p38γ is very low and does not appear to
have a specific proximal–distal pattern. Scale bar=50 μm.
Fig. 2. Inhibition of p38α/β reduces branching morphogenesis in embryonic
lung explants. (A) Whole lung explants isolated from E11.5 mice were treated
with either vehicle (DMSO) or the p38α/β inhibitor SB203580 (10 μM).
Untreated explants were used as a Control. Lungs are shown at the time of
isolation (top row) and after 48 h in culture (bottom row). (B) Graphical
representation of the distal bud count after 48 h in culture. Data are the mean±
SEM from six explants per group. *Pb0.01 compared with either Control or
DMSO groups (one-way ANOVA followed by Bonferroni t-test).
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differentiation, budding/branching. In contrast, at E11.5, p38β
and p38δ transcripts are more uniformly distributed throughout
the proximal and distal endoderm (Figs. 1D and E). Expression
of p38γ appears to be relatively low in both the endoderm and
mesoderm without a difference between proximal and distal
regions (Fig. 1F). Unlike p38α, the expression patterns of
p38β, δ and γ suggest that they are not involved in distal
specific processes.
Inhibition of p38α/β signaling impairs branching
morphogenesis of embryonic lung explants
To test whether p38α is involved in early embryonic lung
branching morphogenesis, whole lungs from E11.5 mice
were cultured in the presence of a pyridinyl imidazole
inhibitor, SB203580, which specifically inhibits the α and β
isoforms of p38 by binding to their activation pockets and
competing with ATP (Fitzgerald et al., 2003). Embryonic
lungs cultured in the presence of 10 μM of SB203580
displayed evidence of impaired branching morphogenesis
with a reduced distal bud count after 48 h compared to
untreated and vehicle (DMSO)-treated explants (Fig. 2).
These results suggest that p38α/β signaling plays a role in
embryonic lung branching morphogenesis.
p38α is required for budding morphogenesis in vitro
To study the function of p38 in early lung branching
morphogenesis and specifically in the developing endoderm, athree-dimensional in vitro culture system was utilized in which
distal lung endoderm is isolated from surrounding mesenchyme
and cultured in growth factor reduced Matrigel in serum-free
medium supplemented with 30 ng/ml FGF7 (Fig. 3A) (Liu et
al., 2004).
Within hours of isolation in culture, the endoderm seals and
forms a vesicle with the apical cell surface facing the lumen.
Later, the endoderm grows and expands into a cyst. At 24–36 h
after culture initiation, numerous secondary buds start to form at
the surface of the cyst (Fig. 3B). Previously, the transcripts of
multiple distal specific genes, such as Bmp4, Erm and Sox9,
have been shown to be preferentially expressed in the
secondary buds (Liu et al., 2003, 2004) indicating that these
secondary buds mimic the distal budding endoderm in
developing lung. Since expression of p38α transcript is also
localized to the distal endoderm (Fig. 1), in situ hybridization
was performed to determine its expression pattern in cultured
lung endoderm. Consistently, p38α transcript is enriched in the
secondary buds (Fig. 3C). This finding further supports the idea
that this three-dimensional embryonic lung endoderm culture
system faithfully imitates budding and branching morphogen-
esis and proximal–distal patterning seen in vivo making it an
excellent model system to study of the function of p38α in the
embryonic lung.
Fig. 3. Morphological responses of cultured endoderm to the treatments of chemical inhibitors of MAPKs. (A) A diagram illustrating the method used to culture
mesenchyme-free lung endoderm. E11.5 embryonic mouse lung endodermwas dissected from mesenchyme, embedded in growth factor reducedMatrigel and cultured
in serum-free media containing 30 ng/ml FGF7. (B) DIC image of endoderm treated with vehicle (DMSO). (C) Whole-mount in situ hybridization of an isolated
endoderm sample grown in the presence of FGF7 (30 ng/ml) using a probe for p38α. Note the presence of numerous secondary buds in response to FGF7 (B) and the
enrichment of p38α transcripts in the secondary buds (arrows) (C). (D) DIC image of endoderm treated with SB203580 (10 μM). In the presence of SB203580, a
chemical inhibitor of p38α/β, the endodermal epithelium forms a cyst that expands but fails to generate secondary buds. (E) Endoderm cultured in the presence of
FGF10 (250 ng/ml) instead of FGF7 and treated with vehicle (DMSO) or (F) treated with SB203580 (10 μM). (G, H) DIC images of the endoderm cultured in the
presence of FGF7 (30 ng/ml) and treated with U0126 (5 μM) (G) or SP600125 (10 μM) (H). In the presence of U0126, chemical inhibitor of ERKs, the endodermal
epithelium forms a cyst with folds inside and no secondary buds are formed (G). In the presence of SP600125, an inhibitor of JNK, the endodermal epithelium forms a
cyst, but the lumen fills with necrotic appearing cells (H). Scale bar=40 μm.
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endoderm, the p38α/β inhibitor, SB203580 was utilized. In the
presence of this p38α/β inhibitor, the isolated lung endoderm
cultured with FGF7 (30 ng/ml) formed hollow cysts, but
consistently failed to develop secondary buds (Fig. 3D).
Inhibition of FGF10 (250 ng/ml) induced secondary budding
was also seen with SB203580 (Figs. 3E–F). While both FGF7
and FGF10 initiate signals downstream of FGFR2IIIb and
induce expression of distal endoderm markers, their budding
phenotypes differ (Bellusci et al., 1997; Izvolsky et al., 2003;
Liu et al., 2003; Weaver et al., 2000). An identical phenotype
was seen with SB202190, another pyridinyl imidazole inhibitor
specific for p38α/β (data not shown). The phenotype seen with
inhibition of p38α/β was distinct from that seen following
treatment with U0126 and SP600125, chemical inhibitors of the
ERK and JNK signaling pathways, respectively (Figs. 3G–H).
In the presence of U0126, an inhibitor to ERK1, ERK2 and
ERK5, FGF7 stimulated endodermal epithelium formed a cyst
with folds inside and no secondary buds (Fig. 3G). In the
presence of SP600125, the FGF7 stimulated endodermalepithelium formed a cyst, but the lumen filled with necrotic
appearing cells (Fig. 3H). These inhibitor studies suggest that
p38α and/or p38β play a role during lung epithelial budding
morphogenesis.
While SB203580 and SB202190 are generally thought to
be relatively specific for p38α/β compared to other chemical
inhibitors of protein kinases (Bain et al., 2003; Davies et al.,
2000), RNA interference was used to confirm the findings
seen with these inhibitors as well as determine whether p38α
or p38β is the major isoform involved in the regulation of bud
morphogenesis. In order to achieve stable knockdown at high
efficiency in the cultured lung endoderm, a lentiviral delivery
system for shRNA was used. As shown in Fig. 4, infection
rates of 100% within the entire epithelial cyst could be
achieved with this viral delivery system. Furthermore, ectopic
genes introduced using lentivirus express as early as 36 h
post-infection and continue to increase for as long as 60 h
post-infection (Figs. 4A–D). The ectopic gene starts to
express at approximately the same time as secondary buds
initiation. Localized expression of p38α to regions of active
Fig. 4. Disrupting p38α in cultured endoderm using lentiviral delivered shRNA. (A–D) GFP was transduced into embryonic lung endodermal epithelium using
lentivirus. (A) GFP expression is barely detectable 24 h post-infection. (B) GFP expression is clearly visible 36 h post-infection. (C) The level of GFP expression
continues to increase at 60 h post-infection. (D) Using this method, transduction of the entire epithelium can be achieved. GFP transduced cells (green) are shown with
nuclei identified by propidium iodide (red). (E–G) Knockdown of p38α using lentiviral delivered shRNA inhibits budding morphogenesis in cultured lung endoderm.
Lentivirus without (E) or with p38α shRNA (F) was used to infect isolated lung endoderm. Note the presence of secondary buds in the lentivirus control (E). Endoderm
transduced with p38α shRNA appears smaller and fails to generate secondary buds (F). (G)Western blot analysis of lung endoderm treated with p38α shRNA indicates
that the levels of p38α are significantly reduced. Protein quantification using densitometric scanning and β-actin as a loading control revealed a 70% reduction in p38α
expression. (H–J) Knockdown of ERK1 using the same lentiviral delivery system does not impair secondary budding. Lentivirus without (H) or with Erk1 shRNA (I)
was used to infect isolated lung endoderm. (J) Western blot analysis of lung endoderm treated with Erk1 shRNA indicates that the levels of ERK1 are significantly
reduced while ERK2 is unchanged. Scale bar=40 μm.
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developmental phenotype in p38β null mice suggest that p38α
is the isoform most likely involved in the regulation of
secondary budding. Therefore, p38α was knocked down using
lentiviral delivered shRNA in lung endoderm cultured in the
presence of FGF7 (Figs. 4E–F). A total of 102 p38α shRNA-
treated lung endoderm cysts were generated using several
independent lentiviral preparations and 80.4% showed a
phenotype similar to those treated with the chemical inhibitor
of p38α/β, with the formation of cysts that lack secondary
bud formation. In contrast, only 6 of 90 control lung buds
(6.7%) failed to develop secondary buds (Table 1). The failure
to see an identical phenotype in 100% of the p38α shRNA-
treated lung buds could be the result of residual p38α
expression due to the infection efficiency and/or shRNA
effectiveness. A second shRNA construct that targets a
different region of p38α also resulted in endodermal cysts
that failed to develop secondary budding (data not shown). InTable 1
Phenotypic score of p38α shRNA-treated endoderm samples
High
(N10)
Moderate
(5–10)
Low
(b5)
No 2nd buds Total % (No
2nd/total)
con 43 27 14 6 90 6.7
p38sh 0 2 18 82 102 80.4contrast, specific shRNA targeting of ERK1 that left ERK2
expression intact did not cause a morphological change in the
cultured endoderm (Figs. 4H–J). While combined inhibition
of ERK1 and ERK2 with U0126 affected budding morpho-
genesis (Fig. 3G), this result is consistent with the lack of a
developmental phenotype in the ERK1-null mouse (Kuida and
Boucher, 2004). Importantly, it indicates that the observed
budding morphogenesis defect seen with p38α shRNA is the
result of p38α knockdown rather than a nonspecific off-target
effect of saturating the endogenous RNAi machinery. Taken
together, the impaired formation of secondary buds resulting
from treatment with either SB203580 or p38α shRNA
strongly suggests that p38α is involved in FGF induced
budding/branching morphogenesis.
Extracellular FGF can regulate p38
While activation of p38 signaling can occur in response to a
wide variety of extracellular stimuli including growth factors, it
is classically thought of as a pathway mediating stress-related
signals. In addition, only limited data exist suggesting that FGFs
can activate p38 signaling. To determine whether activation of
p38 can occur downstream of FGFs known to signal through the
FGFR2IIIb receptor, a mouse lung epithelial cell line (LA-4)
was serum-starved and treated with either FGF7 (Fig. 5A) or
FGF10 (Fig. 5B). The level of p38 activation was determined by
Fig. 5. Extracellular FGF can regulate p38 phosphorylation and p38α
expression. (A, B) FGF7 and FGF10 activate p38 in the LA-4 lung epithelial
cell line. Serum-starved LA-4 cells were treated with either FGF7 (20 ng/ml)
or FGF10 (250 ng/ml) for 0, 5, 10, 15, 30 and 60 min. Lysate were analyzed
by Western blotting for TGY phosphorylated p38 (P-p38) and total p38 (p38).
(C, D) FGF10 induces ectopic p38α expression in the intact lung. BSA (C) or
FGF 10 (D) saturated beads were implanted in the mesoderm of the bronchial
region, where normally only low level of p38α is expressed. After 48 h, p38α
expression was assayed by whole-mount in situ hybridization. Red circles
indicate the position of the implanted beads. Compare the p38α levels in the
regions close to the beads (black arrows) with regions away from the beads
(white arrows).
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the activated form of the kinase that is dually phosphorylated on
the threonine and tyrosine residues within its activation loop
(Figs. 5A–B) (Kang et al., 2006). Both FGF7 and FGF10
stimulation activated p38 in cultured mouse lung epithelial cells
within 5 min. These results suggest that p38 signaling can be
activated downstream of FGF-FGFR2IIIb in lung epithelial
cells.
Enhanced p38α expression in the distal endoderm of
developing lung (Fig. 1) and in secondary buds of isolated
distal endoderm (Fig. 3) also suggests that p38α expression
might be regulated by FGF-FGF2IIIb signaling. To evaluate this
possibility, beads saturated with either BSA (Fig. 5C) or FGF10
(Fig. 5D) were engrafted in the mesoderm adjacent to the
proximal bronchial region of isolated whole embryonic lung
where only low levels of p38α transcript are normally
expressed. After 48 h, an increase in p38α expression was
seen by whole-mount in situ hybridization in the regions
adjacent to the FGF10, but not BSA-soaked beads (Figs. 5D and
C, respectively). Detection of p38α expression in the proximal
endoderm required longer development of the in situ hybridiza-
tion. Nonetheless, these results suggest p38α expression can be
induced by FGF-FGFR2IIIb initiated signaling.p38α is not required for epithelial proliferation and the
expression of distal specific markers
To understand how p38α directs budding morphogenesis,
the effect of impaired p38α signaling on cellular proliferation of
the cultured embryonic lung endoderm was determined since
increased proliferation is seen in the distal regions of active
branching morphogenesis in vivo (Weaver et al., 2000).
Immunohistochemical detection of phospho-histone H3, as a
marker of mitosis and cell proliferation, did not detect an
apparent difference when p38α signaling was disrupted by
either SB203580 or p38α shRNA in the presence of FGF7
(Figs. 6A–F). The mitotic index of vector control versus p38α
shRNA-treated endoderms was calculated as the fraction of
phospho-histone H3-positive nuclei among total number of
nuclei, and no significant difference was seen between the
control (0.156=191/1223) and p38α shRNA (0.174=224/
1284) treatment. In addition, the proliferating cells were
distributed randomly in the endoderm, instead of concentrated
within the secondary buds. This distribution pattern is
consistent with previous data indicating that proliferation is
not an initiating factor in secondary budding (Nogawa et al.,
1998). Thus, it is likely that p38α directs budding morphogen-
esis via a mechanism independent of proliferation.
To determine whether p38α plays a role in regulating the
expression of distal endoderm specific genes, two distal markers
Sox9 and Erm were analyzed in control versus p38α disrupted
endoderm. Western blot analysis suggests that p38α does not
regulate the expression of Sox9 as neither SB203580 nor p38α
shRNA treatment affects its expression level in response to
FGF7 (Fig. 6G and data not shown). Similarly, Erm expression
was evaluated by qRT-PCR. Although the development of
FGF7 induced secondary buds was impaired in SB203580-
treated endoderm, Erm transcript levels remained relatively
unaffected (Fig. 6H). Taken together, these results suggest that
p38α regulation of budding morphogenesis occurs indepen-
dently of changes in cell proliferation or expression of certain
distal lung endoderm markers.
p38α is required for regulating the E-cadherin protein level in
endodermal cells
Other possible mechanisms involved in the initiation and
regulation of budding morphogenesis include the modulation of
cytoskeletal components and/or cell–cell adhesion molecules.
During branching morphogenesis, epithelial cells undergo
coordinated and dynamic shape changes, which may involve
actin cytoskeleton rearrangement. Alexa 488 labeled phalloidin
was used to visualize the distribution of filamentous actin (F-
actin) in the FGF7-stimulated isolated embryonic lung endo-
derm following disruption of p38α signaling. Using this
method, F-actin was detected within the cell cortex region in
control as well as in p38α shRNA- and SB203580-treated lung
endoderm. A dramatic difference in the overall intensity of the
staining was not seen with the disruption of p38α (Figs. 6A and
C). F-actin appeared to be enriched in the budding regions of the
control lung endoderm and in certain regions of the p38α
Fig. 6. Filamentous actin (F-actin) distribution, cell proliferation and distal
marker expression in control and p38α-disrupted endoderm. (A–D) F-actin
distribution and cell proliferation in control (A and B) and p38α shRNA-treated
(C and D) endoderm were evaluated by triple labeling with propidium iodide (B
and D), Alexa Fluor 488 phalloidin (A and C, green) and antibody to phospho-
histone H3 (A and C, blue). Insets show the localized F-actin enrichment. (E and
F) Cell proliferation of endoderm grown in the presence of FGF7 and treated
with either vehicle (DMSO) or SB203580 (10 μM). Proliferating cells were
detected using an anti-phospho-histone H3 antibody (red) and counterstained
with Alexa Fluor 488 phalloidin (green). (G) Western analysis of lysates from
cultured lung endoderm for Sox9 expression (top panel) following treatment
with DMSO (Con) or 10 μM SB203580. The protein level of Sox9 in
SB203580-treated sample was 90% of control as determined by protein
quantification using densitometric scanning. Expression of β-actin (bottom
panel) was measured as a loading control. (H) Transcripts levels of Erm in
control (red) and SB203580 (green)- or U0126 (blue)-treated sample. Cultured
embryonic lung endoderm was treated with DMSO (Con), p38α/β inhibitor
SB203580 (10 μM) or the ERK1/2 inhibitor U0126 (5 μM). Relative
quantification of Erm was determined by two-step qRT-PCR. Data are the
mean±SEM. Scale bar=40 μm.
Fig. 7. Disruption of p38α in cultured endoderm increases E-cadherin protein
level. (A) Lysates from embryonic lung endoderm cultured in the presence of
FGF7 (30 ng/ml) and treated with DMSO (Con) or 10 μM SB203580 (SB) were
immunoblotted for expression of E-cadherin (top panel) and β-actin (bottom
panel). (B) Lysates from embryonic lung endoderm cultured in the presence of
FGF10 (250 ng/ml) and treated with DMSO (Con) or 10 μM SB203580 (SB)
were immunoblotted for expression of E-cadherin (top panel) and β-actin
(bottom panel). (C) Lysates from lung endoderm cultured in the presence of
FGF7 (30 ng/ml) and transduced using control lentivirus (Con) or p38α shRNA
lentivirus (p38αsh) were immunoblotted for expression of E-cadherin (top
panel) and β-actin (bottom panel). (D) Graphical representation of Western
analyses of E-cadherin protein levels resulting from treatment with SB203580 or
p38α shRNA. Quantification was performed by densitometric scanning and
normalized to β-actin expression as a loading control. Relative expression is
depicted with the expression level of the control group in each case arbitrarily
defined as 1.0. Data are the mean±SEM. Each Western blot image is
representative of three independent experiments. (E and F) E-cadherin
localization in control (E) and p38α shRNA (F) transduced endoderm was
detected by fluorescence confocal microscopy. (G) Transcripts levels of E-
cadherin in control and SB203580-treated endoderm cultured in the presence of
FGF7 (30 ng/ml). Cultured embryonic lung endoderm from E11.5 mice was
treated with DMSO (red) or p38α/β inhibitor SB203580 (green). Relative
quantification of E-cadherin was determined by two-step qRT-PCR. Data are
the mean±SEM. Scale bar=40 μm.
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data not shown). Whether these regions represent sites of failed
secondary buds in the p38α disrupted endoderm is not clear.
Nonetheless, these results suggest that p38α can regulate
secondary budding through a mechanism other than F-actin
rearrangement.Regulation of cell–cell interaction is an important mechan-
ism in embryonic development. The amount and distribution of
cell adhesion molecules, such as E-cadherin, in distal tip cells
need to be tightly regulated during branching morphogenesis
(Hirai et al., 1989). Recently, a p38α-binding protein, p38IP,
has been shown to be necessary to control E-cadherin protein
levels during mouse gastrulation (Zohn et al., 2006). To
determine whether p38α regulates E-cadherin levels during
budding morphogenesis of the lung, isolated embryonic lung
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treated with vehicle (DMSO) or SB203580 to inhibit p38α/β
signaling. The levels of E-cadherin protein were compared by
Western blot analysis using β-actin as a loading control.
SB203580 treatment resulted in a two-fold increase in the
amount of E-cadherin protein (Figs. 7A, B). In contrast,
treatment with PD98059 or U0126, chemical inhibitors of
ERKs, did not affect the level of E-cadherin protein expression
in isolated lung endoderm (data not shown).
To verify the role of p38α in the regulation of E-cadherin
expression, embryonic lung endoderm cultured in the presence
of FGF7 was transduced with control virus or virus expressing
p38α shRNA. Consistent with the chemical inhibitor data, the
expression of E-cadherin protein was more than two-fold higher
in endodermal cells in which p38α was knockdown by shRNA
(Fig. 7C). The overall distribution of E-cadherin, however, did
not appear to be affected as immunohistochemical staining
suggests that it is localized at epithelial adherens junctions
(Figs. 7E, F). In addition, qRT-PCR using RNA from control
and SB203580-treated endoderm did not detect a significant
difference in E-cadherin transcripts levels (Fig. 7G). Taken
together, these results suggest that p38α regulates E-cadherin at
a post-transcriptional level, which is consistent with theFig. 8. E-cadherin over-expression impairs budding morphogenesis. (A) Isolated
embryonic lung endoderm was transduced with lentivirus containing either the
empty vector (Control) or E-cadherin-FLAG (E-cadherin) in the presence of
FGF10 (250 ng/ml) for 48 h. (B) Lysates were immunoblotted for E-cadherin,
the FLAG epitope tag, or β-actin (top, middle and bottom panels, respectively).regulation of E-cadherin by p38α and p38IP during gastrulation
(Zohn et al., 2006).
E-cadherin-based adherens junctions undergo dynamic
assembly and turnover that is tightly regulated in order to
allow coordinated cell movement without complete cell
dispersion during development (Gumbiner, 2005). Inhibiting
the ability of E-cadherin to form intercellular junctions has been
shown to disrupt morphogenetic movement and impair
embryonic lung branching morphogenesis (Halbleib and
Nelson, 2006; Hirai et al., 1989). Our results suggest that
altered E-cadherin homeostasis resulting in elevated levels of E-
cadherin can also impair budding morphogenesis. To determine
whether increased E-cadherin expression is sufficient to inhibit
secondary budding, isolated embryonic lung endoderm was
transduced with lentivirus expressing E-cadherin containing a
C-terminal FLAG-tag. The presence of an epitope tag on the C-
terminal end of E-cadherin does not impair its ability to form
intercellular junctions (Adams et al., 1998). Endoderm
transduced with the vector control lentivirus underwent budding
morphogenesis in response to FGF10 (Fig. 8A). On the other
hand, budding morphogenesis was severely impaired in isolated
endoderm transduced with FLAG-tagged E-cadherin (Fig 8A).
Ectopic expression of E-cadherin was verified by Western
analysis (Fig. 8B). This finding suggests that alterations in
normal E-cadherin homeostasis may be sufficient to impair
embryonic lung endoderm budding morphogenesis.
Discussion
Branching morphogenesis is a major process during
embryonic lung development that lays the foundation for the
three-dimensional organization of epithelial-lined airways and
alveoli. While several critical extracellular factors, their cell
surface receptors and the downstream nuclear transcription
factors involved in the regulation of lung branching morpho-
genesis have been identified, little is actually known about the
specific intracellular signaling pathways. This deficit is largely
due to the difficulty in applying techniques used to define
signaling pathways in cultured cells to model systems of
complex organ development. Here, we used a three-dimen-
sional primary endoderm culture coupled with shRNA and
chemical inhibition to identify a role for p38α MAPK in
budding and branching morphogenesis. This study provides the
first evidence that p38 kinase has a specific functional role in
epithelial branching morphogenesis during organogenesis.
In our three-dimensional primary mesenchyme-free endo-
dermal lung epithelium culture system, both chemical inhibition
of p38α/β signaling as well as targeted knockdown of p38α
through RNA interference inhibit the development of secondary
budding. Analysis of developing whole embryonic lung using
in situ hybridization revealed that p38α is the only p38 isoform
specifically expressed in distal endoderm. The relatively
restricted expression of p38α to the regions of active budding
and branching suggests a role for branching morphogenesis. In
contrast, the other p38 isoforms, β, δ, and γ, all have a more
ubiquitous expression pattern in developing lung. In addition,
while a p38δ mutant mouse has not been reported, the lack of a
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disrupted in mice supports the idea that these p38 isoforms
may not have a specific role in branching morphogenesis
(Kuida and Boucher, 2004).
The mechanistic regulation of bud morphogenesis in
developing lung endodermal epithelium is not fully understood
but appears to involve the coordination of a wide variety of
cellular processes including proliferation, cytoskeletal rearran-
gement and cell–cell adhesion. In isolated lung endoderm,
regulation of bud morphogenesis by p38α-dependent signaling
does not appear to involve proliferation. Both chemical
inhibition and RNAi knockdown of p38α did not alter cellular
proliferation as measured by histone H3 phosphorylation. Even
though increased rates of proliferation have been detected in the
branching regions of whole lung endoderm (Weaver et al.,
2000), our finding is consistent with previous data indicating
that proliferation, as measured by BrdU staining, is not involved
in the initiation of bud formation (Nogawa et al., 1998). The
lack of an effect on proliferation may seem surprising since p38
signaling has been implicated in the negative regulation of the
cell cycle in several model systems. In the heart, p38 activation
appears to inversely correlate with normal embryonic cardiac
growth and cardiomyocyte proliferation is increased in cardiac
specific p38α null mice (Engel et al., 2005). Postnatal deletion
of p38α leads to increased proliferation of lung stem and
progenitor cells (Ventura et al., 2007). On the other hand, the
effect of p38α on cellular proliferation is not universal and may
depend on environmental or developmental context or may be
cell type specific. While embryonic p38α inactivation leads to
an increased number of SP-C expressing immature type II cells
in newborn mouse lung, a difference in lung cell proliferation
was not seen with Ki67 and phospho-histone H3 staining (Hui
et al., 2007). Similarly, proliferation was increased in only a
subset of hematopoietic lineages in the embryonic p38α null
mice (Hui et al., 2007).
While impaired p38α signaling inhibited secondary bud
formation, it did not appear to prevent the expression of
previously identified distal endoderm markers, Sox9 and Erm,
in response to FGF7. This finding suggests that cells that
normally form secondary buds undergo certain aspects of
differentiation independent of physical bud formation. Inhibi-
tion of p38α signaling also did not appear to alter actin
rearrangement dramatically in FGF7 induced budding. This
finding is somewhat surprising since p38 signaling is known
to play a significant role in the regulation of actin
polymerization through its downstream targets MAPKAP2
and Hsp25/27 (Herlaar and Brown, 1999). It is possible,
however, that some subtle changes in actin rearrangement
were not detected.
While p38α does not appear to regulate cellular proliferation,
differentiation or actin cytoskeletal rearrangement in early bud
morphogenesis, it does appear to regulate E-cadherin protein
level in developing lung endoderm. Western analysis detected a
2- to 3-fold increase in E-cadherin protein in isolated endoderm
following both chemical inhibition of p38α/β and specific p38α
knockdown. Although indirect immunofluorescence staining
suggested that inhibition of p38α did not alter the overalldistribution of E-cadherin, a clear increase in signal intensity
was not seen by this method. The reason for this discrepancy is
not clear. It is possible that indirect immunofluorescence did not
detect total cellular E-cadherin seen with whole cell lysate
Western blotting or other technical issues prevented detection of
an overall 2- to 3-fold difference in expression. On the other
hand, inhibition of secondary budding with over-expression of
E-cadherin is consistent with the notion that p38α can control
budding morphogenesis through regulation of E-cadherin.
The ability of p38α to regulate E-cadherin levels in
developing lung endoderm appears to occur at a post-
translational level since E-cadherin transcript levels were not
affected significantly with chemical inhibition of p38α.This is
further supported by our finding that expression of two
transcriptional repressors of E-cadherin, Snail and Slug, was
not affected by chemical inhibition of p38α as measured by
qRT-PCR (Fig. S1A). These findings are consistent with the
recent report that p38 signaling is critical for down-regulation of
E-cadherin during mouse gastrulation (Zohn et al., 2006). In
that study, a p38-interacting protein, p38IP, that appears to
interact specifically with the p38α isoform is required for the
activation of p38 leading to the post-translational down-
regulation of E-cadherin expression during the epithelial to
mesenchymal transition (EMT) as cells migrate away from the
primitive streak during gastrulation (Zohn et al., 2006).
While there is no evidence of complete EMT during
branching morphogenesis where cells lose all intercellular
adhesion and polarization, a partial EMT process may occur
where cell–cell adhesion could be regulated to allow coordi-
nated movement of epithelial cells without complete cell
scattering (Gumbiner, 2005). Steady-state regulation of E-
cadherin at adherens junctions typically involves transient
removal of E-cadherin from the cell membrane through
endocytosis and recycling. Signaling involving p38 has been
implicated in the regulation of endosome mediated turnover
leading to lysosomal degradation. Both activation of the small
GTPase Rab5, which facilitates the fusion of early endosomes,
and expression of the small GTPase Rab7, which is responsible
for the transportation from early endosome to late endosomes
and lysosomes, is facilitated by p38 signaling (Bhattacharya et
al., 2006). Pharmacological inhibition of p38α/β signaling
reduced Rab7 mRNA by 50% compared to vehicle (DMSO)
treatment in cultured embryonic lung endoderm (Fig. S1B).
This finding suggests that p38 signaling is required for maximal
Rab7 expression and lysosomal degradation of E-cadherin. The
overall E-cadherin level may regulate the strength of cell–cell
adhesion. The ability of ectopic E-cadherin to impair secondary
budding supports this concept. Accumulation of E-cadherin
from impaired turnover could alter the ability of the developing
lung epithelial cells to undergo collective movement to form
buds. Conversely, reduced expression of E-cadherin mediated
by p38α signaling resulting in fewer adherens junctions could
facilitate coordinated epithelial cell movement and bud
formation.
Regulation of E-cadherin-mediated cell–cell interactions is
important for normal development and has been shown to be
important for bud morphogenesis. In developing salivary
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immediately adjacent to the fibronectin fibrils forming clefts
suggesting that E-cadherin-mediated cell–cell interactions are
replaced with cell–matrix interactions (Sakai et al., 2003). In
developing whole embryonic lung explants, antibody inter-
ference of E-cadherin-mediated cell–cell interactions disrupted
normal budding (Hirai et al., 1989). Our finding that p38α
signaling affects E-cadherin levels and bud morphogenesis
together with these previous findings suggest that tightly
controlled E-cadherin homeostasis is important for bud
morphogenesis.
While it is an in vitro system, our three-dimensional culture
closely mimics certain aspects of in vivo lung development in
that the secondary buds in our endodermal culture show the
characteristic cell shape change and express all distal
differentiation markers examined (Liu et al., 2004). Even
though the endoderm produces certain signaling molecules
such as Bmp4, our mesoderm-free culture is a simplified
system in which the signaling pathways downstream of
isolated mesenchyme-derived signaling molecules, such as
FGF, can be studied in culture. Reduced terminal bud count in
whole lung explants treated with SB203580 suggests that p38α
signaling has a role in branching morphogenesis even in the
presence of additional mesenchyme derived signals. Recently,
an embryo-specific deletion of p38α was reported to result in
perinatal lethality with distorted alveolar structures and
massive infiltration of hematopoietic cells in the lung (Hui et
al., 2007). Whether a defect in branching morphogenesis also
exists is not clear since detailed morphometric analysis of the
lungs prior to the massive hematopoietic cell infiltration was
not performed (personal communication). Targeted deletion in
vivo in the developing distal lung endoderm should allow
additional characterization of the role of p38α in lung
branching morphogenesis.
Branching morphogenesis is a process critical for normal
embryonic lung development. In this study, we specifically
identify p38α as an important signaling intermediate in the
regulation of bud morphogenesis in developing lung. The
apparent mechanism involves the regulation of E-cadherin
expression and presumably epithelial cell–cell interactions.
Given the recent report showing that p38IP regulates gastrula-
tion through p38α and through a post-transcriptional down-
regulation of E-cadherin (Zohn et al., 2006), our findings
suggest a broader role for p38α in the development of
epithelial-derived tissues.
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